Ticker
ABT

Price
100.73
Stock movement up
+0.06 (0.06%)
Company name
Abbott Laboratories
Exchange
(NYSE
,
Currency
USD
)
Sector
Healthcare >
Medical Devices
Market cap
175.06B
Ent value
165.40B
Price/Sales
4.01
Price/Book
2.36
Div yield
2.03%
Div growth
12.14%
Growth years
8
FCF payout
82.13%
Trailing P/E
25.25
Forward P/E
20.81
PEG
2.19
EPS growth
12.40%
1 year return
-3.79%
3 year return
-1.54%
5 year return
8.46%
10 year return
11.83%
Last updated: 2023-09-08
Abbott increased its dividend payout for 51 consecutive years, garnering the popularity and trust of conservative investors. Learn why we initiate our coverage of ABT with outperform rating.
September 29, 2023

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Abbott Laboratories (ABT) stock at Seeking Alpha.
September 28, 2023

iO Charts is a Seeking Alpha partner

DIVIDENDS

Dividend yield - 5y

Loading...
Dividend yield data
Dividend per share2.04
Dividend yield2.03%
Payout frequencyQuarterly
Maximum yield2.29%
Average yield1.66%
Minimum yield1.29%
Discount to avg yield18.03%
Upside potential21.99%
Yield as % of max yield88.35%

Yield distribution (inverse percentile) - 5y

Loading...
Yield distribution data
Dividend yield2.03%
Current yield distribution1.98%
Yield at 100% (Min)1.29%
Yield at 90%1.45%
Yield at 80%1.50%
Yield at 50% (Median)1.64%
Yield at 20%1.83%
Yield at 10%1.90%
Yield at 0% (Max)2.29%

Dividend per share

Loading...
Dividend per share data
Years of growth8 years
CCC statusDividend Challenger
Dividend per share2.04
Payout frequencyQuarterly
Ex-div date13 Jul 2023
EPS (TTM)3.95
EPS (1y forward)4.84
EPS growth (5y)12.40%
EPS growth (5y forward)11.53%

Dividend growth

Loading...
Please create a free account or log in to access this chart
Dividend growth data
ABTS&P500
DGR MR8.51%8.78%
DGR TTM7.53%8.57%
DGR 3 years13.67%4.00%
DGR 5 years12.14%5.65%
DGR 10 years6.93%7.37%
DGR 15 years7.82%5.83%
Time since last change announced300 days
EPS growth (5y)12.40%
EPS growth (5y forward)11.53%

Payout ratio

Loading...
Please create a free account or log in to access this chart
Payout ratio data
EPS coverageFCF coverage
TTM47.73%82.13%
Average--
Forward42.15%-
Loading...
AD

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E25.25
Price to OCF18.27
Price to FCF43.45
Price to EBITDA35.68
EV to EBITDA33.71

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales4.01
Price to Book2.36
EV to Sales3.79
Get the latest news and real-time alerts from Abbott Laboratories (ABT) stock at Seeking Alpha.
September 21, 2023

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Abbott Laboratories (ABT) stock at Seeking Alpha.
September 20, 2023

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count1.74B
EPS (TTM)3.95
FCF per share (TTM)2.30

Income statement

Loading...
Income statement data
Revenue (TTM)43.65B
Gross profit (TTM)24.51B
Operating income (TTM)8.36B
Net income (TTM)6.93B
EPS (TTM)3.95
EPS (1y forward)4.84

Margins

Loading...
Margins data
Gross margin (TTM)56.15%
Operating margin (TTM)19.16%
Profit margin (TTM)15.88%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash9.88B
Net receivables6.22B
Total current assets25.22B
Goodwill22.80B
Intangible assets10.45B
Property, plant and equipment20.21B
Total assets74.44B
Accounts payable4.61B
Short/Current long term debt24.30B
Total current liabilities15.49B
Total liabilities219.00M
Shareholder's equity74.22B
Net tangible assets10.96B

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)9.58B
Capital expenditures (TTM)1.78B
Free cash flow (TTM)4.03B
Dividends paid (TTM)3.31B

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity9.34%
Return on Assets9.31%
Return on Invested Capital7.62%
Cash Return on Invested Capital4.43%
Loading...
AD

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open100.60
Daily high100.82
Daily low99.84
Daily Volume3.29M
All-time high141.46
1y analyst estimate123.97
Beta0.67
EPS (TTM)3.95
Dividend per share2.04
Ex-div date13 Jul 2023
Next earnings date17 Oct 2023

Downside potential

Loading...
Downside potential data
ABTS&P500
Current price drop from All-time high-28.79%-6.74%
Highest price drop-46.27%-56.47%
Date of highest drop23 Jul 20029 Mar 2009
Avg drop from high-11.73%-11.49%
Avg time to new high20 days13 days
Max time to new high1275 days1805 days
Abbott's adjusted diluted EPS payout ratio is going to expand significantly from the mid-30% range in 2022 to the mid-40% range in 2023. Read more on ABT stock.
September 17, 2023

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Abbott Laboratories (ABT) stock at Seeking Alpha.
September 13, 2023

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
ABT (Abbott Laboratories) company logo
Marketcap
175.06B
Marketcap category
Large-cap
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Employees
115000
SEC filings
CEO
Robert Ford
Country
USA
City
Abbott Park
Stock type
Common stock
CCC status
Dividend Challenger
Dividend Frequency
Quarterly
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
Get the latest news and real-time alerts from Abbott Laboratories (ABT) stock at Seeking Alpha.
September 6, 2023

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Abbott Laboratories (ABT) stock at Seeking Alpha.
September 5, 2023

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
Get the latest news and real-time alerts from Abbott Laboratories (ABT) stock at Seeking Alpha.
August 29, 2023
Get the latest news and real-time alerts from Abbott Laboratories (ABT) stock at Seeking Alpha.
August 5, 2023
Abbott Laboratories has experienced a slowdown in growth due to the COVID-19 pandemic and a decline in demand for diagnostic products. Click here to read more.
July 31, 2023
Abbott's four major segments address key health issues and show impressive organic sales growth. Read why I have a buy rating on ABT stock.
July 31, 2023
Get the latest news and real-time alerts from Abbott Laboratories (ABT) stock at Seeking Alpha.
July 21, 2023
Abbott Laboratories (NYSE:NYSE:ABT) Q2 2023 Earnings Conference Call July 20, 2023 9:30 AM ETCompany ParticipantsMike Comilla - Vice President, Investor...
July 20, 2023
Get the latest news and real-time alerts from Abbott Laboratories (ABT) stock at Seeking Alpha.
July 20, 2023
Get the latest news and real-time alerts from Abbott Laboratories (ABT) stock at Seeking Alpha.
July 20, 2023
Get the latest news and real-time alerts from Abbott Laboratories (ABT) stock at Seeking Alpha.
July 18, 2023
I am expecting positive Abbott Laboratories Q2 '23 earnings. ABT stock is showing resilience in a bearish period for healthcare. Click for my ABT earnings preview.
July 17, 2023
iO Charts is a Seeking Alpha partnerNext page